Advertisement
Advertisement
COSM
Cosmos Holdings Inc. Common Stock
0.22
USDSponsored
-0.01
-4.08%
Aug 10, 15:59 UTC -4
Closed
After-Market
0.23
0.00
+0.67%
COSM Earnings Reports
Positive Surprise Ratio
COSM beat 1 of 6 last estimates.
17%
Next Report
Date of Next Report
Aug 24, 2026
Estimate for Q2 26 (Revenue/ EPS)
$19.81M
/$0.01
Implied change from Q1 26 (Revenue/ EPS)
+10.49%
/-116.67%
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Cosmos Holdings Inc. Common Stock earnings per share and revenue
On May 20, 2026, COSM reported earnings of -0.06 USD per share (EPS) for Q1 26, missing the estimate of -0.01 USD, resulting in a -488.24% surprise. Revenue reached 17.93 million, compared to an expected 22.11 million, with a -18.90% difference. The market reacted with a -10.20% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.01 USD, with revenue projected to reach 19.81 million USD, implying an decrease of -116.67% EPS, and increase of 10.49% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ZOETIS INC.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.87
Actual
$1.87
Surprise
-0.22%
Oruka Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.52
Actual
-$0.55
Surprise
-4.62%
Definium Therapeutics, Inc. Common Shares
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.55
Actual
-$1.44
Surprise
-158.25%
Guardian Pharmacy Services, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.27
Actual
$0.28
Surprise
+3.76%
Cronos Group Inc. Common Share
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.03
Surprise
0.00%
Relmada Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.20
Actual
-$0.11
Surprise
+45.95%
Avita Medical, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.25
Surprise
+14.50%
SIGA Technologies Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-Actual
$0.17
Surprise
-
Tonix Pharmaceuticals Holding Corp.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$2.75
Actual
-$2.44
Surprise
+11.29%
Fractyl Health, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.85%
FAQ
What were Cosmos Holdings Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Cosmos Holdings Inc. Common Stock reported EPS of -$0.06, missing estimates by -488.24%, and revenue of $17.93M, -18.9% below expectations.
How did the market react to Cosmos Holdings Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -10.2%, changed from $0.28 before the earnings release to $0.26 the day after.
When is Cosmos Holdings Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 24, 2026.
What are the forecasts for Cosmos Holdings Inc. Common Stock's next earnings report?
Based on --
analysts, Cosmos Holdings Inc. Common Stock is expected to report EPS of $0.01 and revenue of $19.81M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement